FDA Updates IDE Guidance Addressing Medicare Coverage
CMS may have an easier time determining when it should pay for an investigational device as FDA revamps its IDE device-classification scheme.
You may also be interested in...
The agency has long been partnering with CMS to set coverage for investigational device exemption studies by designating IDE trials as "category A" or "category B." A new FDA draft guidance and memorandum of understanding between FDA and CMS are intended to modernize the criteria for those trial categories.
Already cleared to monitor the viral load in HIV-positive individuals, the test has now been approved for initial diagnosis as well.
Attorneys tell Medtech Insight a recent proposal to review regulations every 10 years could lift some burdens from the medical device industry, but warned that the full effects may not be seen for some time.